Seer

At Seer, we develop innovative solutions that act as a gateway to the proteome. We develop solutions to enable unbiased, deep, rapid, proteomics at scale.

[Seer @seer_bio]

For the 2nd year in a row, #Seer ranked as one of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast500™ https://t.co/ddlEY7auOT

#Proteomics #Collaboration #Innovation #LifeSciences #HealthTech #Fortune500 #Biotech #ScientificInnovation

[Seer @seer_bio]

Join us Tues, Nov 19th @ 15:15 CET at Czech Annual Cancer Research Meeting where Maik Pruess, PhD, Sr. Field Application Scientist presents ‘Early Cancer Detection & Prevention: Unraveling the proteome by untargeted mass spectrometry proteomics at scale.’ https://t.co/vRi6gIqLwI

[Seer @seer_bio]

Seer’s collaboration with Thermo Fisher Scientific expands the global reach of Seer's Proteograph™ Product Suite, empowering more researchers with access to transformative proteomics technology.

#Proteomics #LifeSciences #ThermoFisher

[Seer @seer_bio]

Transforming proteomics! Seer & Thermo Fisher Scientific join forces to accelerate breakthroughs in life sciences. Our collaboration enables seamless sample-to-data workflows, unlocking deeper insights in human biology & disease.

#Proteomics #LifeSciences #ThermoFisher

[Seer @seer_bio]

We’re thrilled about the groundbreaking collaboration btw Seer & #ThermoFisher Scientific! By combining Seer’s Proteograph™ w/ Thermo Scientific™ Orbitrap™ Astral™, we’re enabling deep, unbiased #proteomics for impactful data & insights https://t.co/Q4urWI8O0k

#LifeSciences

[Seer @seer_bio]

Thank you for visiting us at #ASHG24! We would love to continue to explore how we can help you push your #genomicsresearch forward with the power of #proteomics and our #Proteograph technology.​ We invite you to schedule a follow-up 1:1 here: https://t.co/drt4jAN87h

[Seer @seer_bio]

We're thrilled to announce a new co-marketing and sales agreement with @thermosci that will provide researchers with a powerful, scalable solution for deep, unbiased #proteomics analysis at scale. https://t.co/85ONkFVGZu

[Seer @seer_bio]

Congratulations to @PrognomiQ_Inc for their groundbreaking work leveraging multi-omics data to advance early detection testing for lung cancer, paving the way to transform patient outcomes and impact millions of lives. Seer's honored to be your partner on this remarkable journey.

[PrognomiQ Inc @PrognomiQ_Inc]

Today, PrognomiQ has announced the company's Series D financing of $34 million to help advance our company's development of an early detection test for #LungCancer. Learn more about this significant milestone: https://t.co/VCmv5iy8Uv

[Seer @seer_bio]

Today's the day! Please join us this afternoon at #ASHG24 for this exciting 2-part CoLab that will highlight proteogenomic breakthroughs leveraging the Proteograph. Here are the exceptional speakers and the details: https://t.co/LCH5TzXTHy

[Seer @seer_bio]

Proteogenomics may provide novel insights into Alzheimer’s disease pathophysiology. Join us #ASHG24 as Harendra Guturu shares a study examining the impact of genetic variation on protein abundance to reveal the potential functional implications in AD.
​https://t.co/LCH5TzXTHy

[Seer @seer_bio]

At #ASHG24 Nov. 6: Join @s_batzoglou as he presents insights into a GWAS using mass spec. and our Proteograph with blood samples from a discovery cohort. Learn what they identified, replicated and the powerful combination for proteomics and pQTLs research. https://t.co/LCH5TzXTHy

[Seer @seer_bio]

This scientific presentation at @GeneticsSociety #ASHG24 will showcase the exceptional work by Brendan Keating et al at @nyugrossman and highlight the power of plasma proteomics using the Proteograph in multi-omics research. Join us! Nov. 6, 11:15-11:30am. https://t.co/LCH5TzXTHy

[Seer @seer_bio]

An exciting 2-part CoLab at @GeneticsSociety #ASHG24! This session will highlight #proteogenomic breakthroughs that leveraged Seer’s #Proteograph Product Suite. We invite you to join us. Learn more here: https://t.co/LCH5TzXTHy

[Seer @seer_bio]

We're just a few days away from @GeneticsSociety's #ASHG24 in Denver. While attending, we'd welcome the opportunity to connect, learn about your research, and share how the #Proteograph is enhancing #proteogenomic studies. Visit our team at Booth 335! https://t.co/LCH5TzXTHy

[Seer @seer_bio]

We're looking forward to joining everyone at @GeneticsSociety #ASHG24. Scientists are leveraging the Proteograph to uncover novel biological insights in their proteomics and genomics research. We'd love to explore how our technology can support your work. https://t.co/LCH5TzYrx6

[Seer @seer_bio]

Thank you to everyone who connected with us at #HUPO2024 and to @hupo_org for such an engaging, informative conference. We were pleased to have the opportunity to join many important research discussions with incredible #scientists from around the world. https://t.co/eBwn3RXWS4

[Seer @seer_bio]

Have you visited our photo booth at #HUPO2024 yet? There’s still time! Bring your industry friends and colleagues and drop by our Booth 20 and take some pics. The Seer team would love to meet you.

[Seer @seer_bio]

Thank you to everyone who attended Alexey Sukolav's #HUPO2024 presentation today, offering further insights into this important and amazing study done at NYU Langone Transplant Institute. Please visit our team at Booth 20 if you would like to discuss this research in more detail.

[Seer @seer_bio]

At @hupo_org #HUPO2024: We invite you to join Harendra Guturu's, PhD, poster presentation: Understanding the impact of genetic variants on Alzheimer's disease with mass spectrometry proteogenomics. Date: October 23. Time: 13:00. P-III-1031.​ #Proteograph https://t.co/Gh62pr1I1j

[Seer @seer_bio]

Don't miss @Lee_S_Cantrell 's, PhD, poster presentation at @hupo_org #HUPO24: Empowering robust population-scale MS plasma proteomics studies with nanoparticle enrichment. Today starting at 13:15! P-I-0212.​ https://t.co/Gh62pr1I1j